Editors’ Picks, April 2026: Immunotherapy-boosting Bacteria, GLP-1 Agonists for Breast Cancer Survivors, and More
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.








